(Q45710750)

English

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12 (English)

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Semliki Forest virus

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567611

23 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567611

23 March 2024

1

object named as

Ryuya Yamanaka

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567611

23 March 2024

author name string

Naoto Tsuchiya

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Naoki Yajima

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Junpei Honma

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hitoshi Hasegawa

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Ryuichi Tanaka

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Jay Ramsey

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

R. Michael Blaese

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567611

23 March 2024

Kleanthis G. Xanthopoulos

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567611

23 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

full work available at URL

https://thejns.org/view/journals/j-neurosurg/99/4/article-p746.xml

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

https://thejns.org/downloadpdf/journals/j-neurosurg/99/4/article-p746.xml

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Journal of Neurosurgery

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

746-753

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

8

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

12

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

17

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence.

19

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.

31

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Chapter 3 Recombinant Sindbis Virus as an Expression System for Cell Biology

34

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

36

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

40

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

41

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma.

45

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.

50

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

51

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.

52

1 reference

10.3171/JNS.2003.99.4.0746

https://api.crossref.org/works/10.3171/JNS.2003.99.4.0746

23 March 2024

Identifiers

10.3171/JNS.2003.99.4.0746

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45710750&oldid=2110144786"